A trial fibrillation (AF) is a frequent complication of longstanding hypertension and represents the most common cardiac arrhythmia causing significant morbidity and mortality.
A trial fibrillation (AF) is a frequent complication of longstanding hypertension and represents the most common cardiac arrhythmia causing significant morbidity and mortality. [1] [2] [3] During AF, normal atrioventricular (AV) node conduction leads to a rapid and irregular ventricular rate, resulting in an impairment of left ventricular function and exercise capacity. 4 Rate control can be achieved by drugs modulating the autonomic nervous system, for example, by β-blockers. Genetic inhibition of inhibitory Gα protein in the AV node reduced heart rate (HR) and prevented AF-associated reduction of cardiac function in a porcine model for persistent AF. 5 In addition, AF causes atrial electrical remodeling mainly characterized by a pronounced atrial effective refractory period (AERP) shortening perpetuating AF. 6 Alterations in the autonomic nervous system may influence AF-induced atrial electrical remodeling and atrial arrhythmogenesis. [7] [8] [9] Catheterbased renal denervation (RDN) is a new therapeutic approach to reduce sympathetic activity and blood pressure (BP) and to improve obstructive sleep apnea severity and glucose metabolism in resistant hypertension. [10] [11] [12] [13] [14] [15] However, the effect of RDN on ventricular HR response during AF (rate control) and AF-induced electrical remodeling is unknown.
Herein, we report on the effect of catheter-based RDN, shown previously to reduce renal and whole body sympathetic activity, [12] [13] [14] on rate control in a patient with permanent AF and resistant hypertension. Subsequently, we investigated the effect of denervation of the afferent and efferent renal sympathetic nerves in a pig model with short-term AF maintained by rapid atrial pacing.
Methods

Catheter-Based RDN in a Patient With AF
The patient gave written informed consent. Catheter-based RDN was performed as described previously. [11] [12] [13] [14] [15] Renal angiogram was performed via femoral access to exclude renal artery stenosis. The treatment catheter (Symplicity Catheter System, Ardian/Medtronic USA) was introduced into each renal artery using a guiding catheter (internal mammary artery), and ablations were performed in both renal arteries using a standardized treatment protocol and algorithm. Five energy deployments for 120 s with 8 watts each were performed in the right and 4 in the left renal artery. Treatments were delivered from the first distal main renal artery bifurcation to the ostium proximally and were spaced longitudinally and rotationally under fluoroscopic guidance. Morphine and midazolam were administered to manage visceral pain during the energy delivery. Baseline and follow-up procedures at 3, 6, and 12 months consisted of an assessment of BP (Spacelab 90207 device), recording of a resting electrocardiogram (ECG), a 24-hour Holter ECG, and review of medication. To minimize the influence of confounding factors, ECG and BP were obtained at the same daytime 1 to 2 hours after intake of antihypertensive medications. Recording of a 12-lead ECG was performed after 10 minutes of supine rest at standard sensitivity (10 mm = 1 mV) and a paper speed of 50 mm/s. ECGs were analyzed concerning HR and rhythm as described elsewhere. 16 Polymorphic premature ventricular beats were quantified per 24 hours.
Pig Model for AF
All of the animal studies were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (publication No. 85-23, revised 1996). In 12 chest-closed male castrated pigs (25-30 kg) of the German Landrace (anesthetized with 20% urethane, 0.8 mL/kg IV load, 0.4 mL/kg per hour of maintenance) and 4% α-chloralose (0.4 mL/kg IV load, 0.1 mL/kg per hour of maintenance), a tracheotomy was performed to place an endotracheal tube. 17 Blood pressure was measured by a Millar tip catheter (Millar PC 350; Millar Instruments, Houston, TX) in the femoral artery. Bipolar body surface ECG was recorded using subcutaneous needle electrodes in the classic lead II arrangement. The ECGs were analyzed before and after RDN. In all of the animals, both kidneys were approached through bilateral retroperitoneal flank incisions. In 7 animals, both kidneys were surgically denervated by cutting all of the visible nerves in the area of the renal hilus and by stripping ≈1 cm of the adventitia from the renal artery. The area was then moistened with a 20% phenol/ethanol solution for 10 to 15 minutes. Left renal flow was measured with a doppler flow probe (transit time flowmeter module system from Transonic Systems Inc) positioned on the blood vessels. After RDN, the animals were allowed to re-equilibrate for 1.5 hours. Significant reduction of a reproducible postapneic BP rise and the absence (<5% change) of a decrease in renal blood flow induced by tracheal occlusion for 2 minutes were taken as evidence of the completeness of RDN. 17 Sham surgical procedure with kidney exposition without RDN was performed in the 5 other pigs serving as time controls.
Electrophysiological Examinations in Pigs
Atrial responses to the pacing procedure were visualized by monophasic action potential (MAP) recordings from the endocardium of the right atrium by a MAP pacing catheter (combined MAP and stimulation catheter, 7F catheter, Foehr Medical Instruments GMBH, Seeheim, Germany). The catheter was inserted via a femoral vein. The tip of the catheter was advanced to the lateral right atrium to record a stable and sharp MAP signal. Determination of the diastolic pacing threshold (0.5-1.0 mV) before each tracheal occlusion maneuver revealed no significant changes during the experimental period. A train of 10 basic stimuli (S1, pulse duration 1 ms) at twice diastolic pacing threshold was followed by an extra stimulus (S2) starting at ≈30 ms below the expected AERP with a 5-ms increment (UHS 20, universal heart stimulator; Biotronik, Berlin, Germany). The shortest coupling interval able to elicit a propagated atrial response was taken as the AERP. AERP was measured at different stimulation frequencies (basic cycle length, 240, 300, and 400 ms) before and after RDN, as described previously. 18 The AV node effective refractory periods and the longest cycle length of atrial pacing causing second-degree AV nodal block (antegrade Wenckebach point) were determined. To deliver rapid atrial pacing (basic cycle length, 50 ms) for 30 minutes, a second 7F bipolar catheter was inserted in the right atrial appendage. After each 15 minutes, rapid atrial pacing was temporally stopped for AERP measurements at a basic cycle length of 240, 300, and 400 ms. During the AERP measurement procedure the shortest premature S2 extrastimulus resulting in a propagated response frequently induced episodes of AF. When atrial MAP signals showed an irregular rapid activation (cycle length, <200 ms; duration, >5 seconds), AF was diagnosed. The mean percentage of AERP measurement triggering AF was used to describe AF inducibility. To determine the mean atrial and mean ventricular cycle length during AF, the AA-and RR-intervals, respectively, were measured over a 5-second interval and averaged. 18 All in all, 5 consecutive AF episodes per animal and per time point have been analyzed and averaged.
Statistics
Data are presented as mean±SEM. For comparisons of single repeated measures only, a paired Student t test was used. For multiple repeated-measures comparisons with the same baseline, repeatedmeasures 2-way ANOVA was used followed by the Dunnet test to compare individual mean difference if ANOVA was significant. A P value <0.05 was considered significant. For all of the statistical calculations software Everstat version 5 based on SAS 8 was used.
Results
Clinical Observations: Effect of RDN in a Patient With Permanent AF
The patient was a 71-year-old, severely hypertensive male with a history of resistant hypertension for >20 years, 2-vessel coronary artery disease, and left ventricular hypertrophy. Secondary causes of hypertension had been excluded systematically several times. Despite full-dose antihypertensive treatment with a calcium channel blocker (lecarnidipine 10 mg daily), an angiotensin-converting enzyme inhibitor (enalapril 40 mg daily), a β-blocker (bisoprolol 10 mg daily), a hydrochlorothiazide (25 mg), a loop diuretic (torsemide 10 mg), and an angiotensin receptor blocker (olmesartan 40 mg), the patient was poorly controlled (office BP at baseline, 172/90 mm Hg; 24-hour BP, 156/90 mm Hg, nondipper). The patient was in permanent AF with a baseline resting HR of 88 bpm. Twenty-four-hour Holter ECG revealed AF with a mean HR of 91 bpm and frequent polymorphic premature ventricular beats (5085 per day). The patient subsequently underwent catheterbased RDN of both renal arteries. There were no procedural or periprocedural complications. At 3, 6, and 12 months of follow-up, office BP was reduced by 31/11, 28/12, and 29/11 mm Hg, respectively. The office BP reductions were confirmed by ambulatory BP monitoring: 6 and 12 months after RDN, 24-hour BP decreased by 21/3 mm Hg and 19/11 mm Hg, respectively. Resting HRs at 3, 6, and 12 months were reduced to 64 (−24 bpm), 69 (−19 bpm), and 61 (−27 bpm). Twenty-four-hour mean ventricular HR decreased by 20 and 31 bpm at 6 and 12 months of follow-up, indicating rate control after RDN. Other than the reductions in resting and 24-hour HRs, the numbers of premature ventricular beats were 483 and 230 per day, demonstrating a significant decline. The patient underwent cardiopulmonary exercise testing before and 3 months after RDN with measurement of BP and HR at resting, 25%, 50%, and 75% and maximum achieved workload. Three months after RDN, HR and BP ( Figure 1 ) were reduced at all exercise levels, whereas the maximum workload increased from 150 to 157 W. Of note, no BP-or HR-influencing medications were added and no dose adjustments were made during follow-up. Figure 2 shows ECG parameters in sham and RDN pigs during sinus rhythm. RDN reduced HR by ≈17% (sinus cycle length, 708±12 versus 577±19 ms in sham; P=0.0021), and PQ-interval was prolonged by ≈29% (PQ-interval, 112±12 versus 88±9 ms in sham; P=0.0001), whereas P-wave duration was not changed by RDN.
Experimental Observations in Pigs: Electrophysiological Effects of RDN on ECG
Effect of RDN on Atrial Refractoriness, Electrical
Remodeling, and AV Nodal Conduction Figure 4C ) and after RDN ( Figure 4D ) is shown. Figure 5A shows representative atrial multiple action potentials during AERP measurement and during AF induced by the premature stimulus (S2) after 30 minutes of atrial tachypacing. Increased AF inducibility after atrial tachypacing was not changed by RDN ( Figure 5B ). AF cycle length ( Figure  5C ) after 30 minutes of atrial tachypacing was decreased compared with baseline and not further modulated by RDN. However, after 30 minutes of atrial tachypacing, duration of induced AF episodes ( Figure 5D 
Effect of RDN on AF
Discussion
RDN provided rate control by reducing resting HR, 24-hour HR, and HR during exercise in a patient with permanent AF other than marked reduction of BP and polymorphic premature ventricular beats. This observation motivated a subsequently conducted experimental pig study. RDN reduced HR as well as AV nodal conduction in pigs during sinus rhythm, prolonged AV node effective refractory period and antegrade Wenckebach point, and provided efficient rate control during induced AF. Duration of induced AF episodes was shortened after RDN when compared with sham. However, atrial tachypacing-induced AERP shortening and intra-atrial conduction (P-wave duration), increased AF inducibility (electrical remodeling), and BP was not modified.
The autonomic nervous system affects electrophysiological properties like chronotropy and dromotropy. 19 In the present study, RDN reduced HR during sinus rhythm, potentially because of alterations in sympathetic activity by RDN. This is of interest because HR reduction has become a therapeutic target in many cardiovascular diseases. 20 The Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial has shown a reduction by 18% of cardiovascular death and hospitalization for heart failure in patients with systolic heart failure, in whom a 5-bpm higher HR at baseline corresponded with a 15% higher risk. 21, 22 In addition, RDN modified AV nodal conduction time, AV node effective refractory period, and antegrade Wenckebach point, whereas P-wave duration was unchanged. AV conduction slowing by RDN resulted in decreased ventricular rate in a patient with permanent AF and in pigs with induced AF by ≈24%. The effect is comparable to pharmacological rate control 23 and AV gene therapy in recent studies. 5 However, pharmacological rate control in AF is limited by reduced efficacy, adverse effects, and safety issues in a large amount of patients. 24 Nonpharmacological approaches like AV node vagal stimulation, moderate physical exercise, and genetic inhibition of inhibitory Gα protein in the AV node have been successfully tried to overcome these limitations. 5, 25, 26 Our data indicate that RDN may provide an additional promising strategy for rate control in AF. This rate control effect was observed in a hypertensive patient with permanent AF other than marked BP reductions. However, rate control by RDN appears to be independent of changes in BP, because BP was not changed in normotensive pigs in our study.
ECG-intervals (ms)
AERP shortening induced by AF maintained by atrial tachypacing (electrical remodeling) was not modified by RDN. In a goat model of AF, Wijffels et al 6 showed that artificial maintenance of AF leads to a marked shortening of the AERP, a reversion of its physiological rate adaptation, and a decrease in AF cycle length together with increased inducibility and stability of AF (AF begets AF). This atrial electrical remodeling during AF was not mediated by changes in autonomic tone, because it was not prevented by atropine or β-receptor blockade in goats. 27 However, rapid atrial pacing failed to shorten the AERP in dogs with ganglionated plexi ablation or autonomic blockade. This suggests that the intrinsic cardiac autonomic nervous system may contribute to the pathophysiology of atrial electrical remodeling. 28 In a recent study we showed that sensitivity of ganglionated plexi (representatives of the intrinsic cardiac autonomic nervous system) was not modulated by RDN. 29 Other mechanisms beyond changes in autonomic tone, which are not modulated by RDN, seem to play a more relevant role for atrial electrical remodeling during AF. Atrial electrical remodeling results mainly from calcium overload induced by frequent depolarizations (rapid atrial pacing), leading to alterations of ion currents, especially decreased l-type calcium current, which subsequently shortens the atrial action potential duration and refractoriness. 7 Although AF-induced AERP shortening and AF cycle length during induced AF were unchanged after RDN, duration of induced AF episodes was shorter. This suggests that mechanisms other than atrial refractoriness account for shorter AF episodes after RDN. Unchanged P-wave duration excludes pronounced changes in intra-atrial conduction. There is evidence suggesting that the autonomic nervous system plays an important role in both the initiation and the maintenance of AF in humans. [30] [31] [32] [33] Consistently, β-receptor blockade by metoprolol has been shown to maintain sinus rhythm after conversion from persistent AF in humans. 34 RDN may display comparable effects. In addition, the activity of the intracardiac autonomic nervous system may be increased by rapid atrial pacing. 35, 36 Modulation of the autonomic nervous system has been shown to influence neural remodeling during AF. Thoracic epidural anesthesia reduced afferent and efferent sympathetic nerve impulse and prevented sustained AF promoted by rapid atrial pacing. This was associated with inhibition of atrial nerve sprouting. 37 In contrast, cryoablation of sympathovagal nerves did not achieve the same effect in a similar model. 32 These data suggest that a blockade of afferent and efferent sympathetic fibers is more effective than elimination of cardiac efferent nerve fibers by ablation alone. Ablation of the afferent and efferent renal sympathetic nerves by RDN has been shown to reduce renal and whole body sympathetic activity. 10 Attenuation of atrial tachycardia-induced structural remodeling cannot account for shorter AF episodes after RDN in our study because the structural changes of the atria would require at least several days of pacing. 7 Importantly, other than reduced inducible AF duration, increased AF inducibility by applied premature atrial stimuli was not influenced by RDN. Whether RDN can inhibit spontaneous triggers for AF (eg, spontaneous premature atrial extra beats) remains unknown. The first supportive data for potential antiarrhythmic effect of acute RDN have been published recently. Ukena et al 38 reported reduced ventricular tachyarrhythmias in patients with electrical storm and congestive heart failure after catheter-based RDN. In addition, RDN inhibited pronounced shortening of AERP and increased AF susceptibility in a pig model for obstructive sleep apnea. 30 Whether RDN may provide rate control in a larger number of patients with AF deserves further clinical studies.
Limitations
One might suggest that catheter-based RDN does possibly not completely abrogate renal sympathetic nerves, as indicated by a norepinephrine spillover reduction by ≈50%. Herein, we performed combined surgical and chemical renal nerve ablation, which might be more complete compared with the catheter-based approach. However, in pilot studies, it has been shown that norepinephrine reduction in the kidney was similar to catheter-based RDN and surgical RDN by ≈60% (Paul A. Sobotka, personal communication, unpublished data). In addition, spontaneous occurrence of AF was too rare for a systematic evaluation. In patients with AF, Holter monitoring showed that paroxysmal AF is induced by spontaneous premature atrial beats in ≈74.3%. 39 Therefore, we applied a premature beat to induce AF, representing a good parameter to characterize atrial vulnerability. 6, 7, 16, 17, 28 Moreover, only short-term effects of RDN could be investigated through the experimental approach used in the animals of this study. The long-term effects of RDN on AF and its recurrence are still to be explored in animal models for permanent AF.
Conclusions and Perspectives
During sinus rhythm, RDN reduces HR and prolongs AV nodal conduction. AV conduction slowing by RDN resulted in efficient rate control during AF. The duration of induced AF episodes was shortened after RDN. However, AF-induced AERP shortening, P-wave duration, and AF inducibility (electrical remodeling) were not altered. RDN displays acute antiarrhythmic effects without changing atrial refractoriness or BP. Modulation of the autonomic nervous system by RDN provides efficient rate control during AF and might be useful to reduce susceptibility to AF in patients with paroxysmal AF. RDN deserves to be tested in AF models for chronic AF with structural, electrical, or neural atrial remodeling and in clinical studies. Whether RDN may provide rate control in a larger number of patients with AF deserves further clinical studies.
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